Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹2,363 Cr
up ₹19.4 Cr vs Apr 2024
- Stocks held
- 26
- unchanged
- Top 10 weight
- 67.7%
- of the portfolio in its ten largest
- Cash & debt
- 1.3%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 15
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In May 2024 it disclosed 26 stocks worth ₹2,363 Cr, up ₹19.4 Cr from Apr 2024. Its largest positions were Sun Pharmaceutical Industries Limited (12.6%), Cipla Limited (8.5%), IPCA Laboratories Limited (7.8%); the ten largest together made up 67.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 68.5% of its equity. Cash and debt stood at 1.3%. Compared with Apr 2024 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
10%
Holds more stocks than 10% of peers
Cash
14%
Holds more cash than 14% of peers
What these mean: concentration · cash
Holdings in May 2024
Download CSVEvery line the fund disclosed, with the change against Apr 2024. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 12.59% | down 0.47 pts | ₹297 Cr | down ₹8.6 Cr | Trimmed |
| Cipla Limited | 8.49% | up 0.82 pts | ₹201 Cr | up ₹20.9 Cr | Added |
| IPCA Laboratories Limited | 7.82% | down 1.35 pts | ₹185 Cr | down ₹30.1 Cr | Trimmed |
| Suven Pharmaceuticals Limited | 7.56% | down 0.60 pts | ₹179 Cr | down ₹12.5 Cr | Trimmed |
| Lupin Limited | 7.32% | down 0.36 pts | ₹173 Cr | down ₹6.9 Cr | Trimmed |
| Alembic Pharmaceuticals Limited | 5.56% | down 0.51 pts | ₹131 Cr | down ₹10.9 Cr | Trimmed |
| Globus Medical Inc | 5.51% | up 1.57 pts | ₹130 Cr | up ₹37.8 Cr | Added |
| Apollo Hospitals Enterprise Limited | 4.60% | down 0.12 pts | ₹109 Cr | down ₹2 Cr | Trimmed |
| Zydus Lifesciences Limited | 4.39% | up 0.17 pts | ₹104 Cr | up ₹4.8 Cr | Added |
| Concord Biotech Limited | 3.87% | down 0.57 pts | ₹91.4 Cr | down ₹12.7 Cr | Trimmed |
| Vijaya Diagnostic Centre Limited | 3.51% | up 0.47 pts | ₹82.9 Cr | up ₹11.6 Cr | Added |
| Procter & Gamble Health Limited | 3.16% | down 0.17 pts | ₹74.6 Cr | down ₹3.3 Cr | Trimmed |
| Alkem Laboratories Limited | 2.97% | down 0.04 pts | ₹70.1 Cr | down ₹33 L | Held |
| Kovai Medical Center and Hospital Limited | 2.93% | down 0.02 pts | ₹69.3 Cr | up ₹18 L | Held |
| Intuitive Surgical Inc | 2.66% | up 0.18 pts | ₹62.9 Cr | up ₹4.8 Cr | Added |
| Indoco Remedies Limited | 2.66% | up 0.30 pts | ₹62.8 Cr | up ₹7.5 Cr | Added |
| Illumina Inc | 1.93% | up 1.03 pts | ₹45.5 Cr | up ₹24.6 Cr | Added |
| Unichem Laboratories Limited | 1.69% | down 0.15 pts | ₹39.9 Cr | down ₹3.3 Cr | Trimmed |
| ICICI Lombard General Insurance Company Limited | 1.61% | down 0.15 pts | ₹38.2 Cr | down ₹3.1 Cr | Trimmed |
| Narayana Hrudayalaya Limited | 1.50% | down 0.14 pts | ₹35.4 Cr | down ₹2.9 Cr | Trimmed |
| Aarti Drugs Limited | 1.49% | down 0.10 pts | ₹35.2 Cr | down ₹2 Cr | Trimmed |
| Taro Pharmaceutical Industries Limited | 1.35% | down <0.01 pts | ₹31.9 Cr | up ₹17 L | Added |
| Cash, TREPS & receivables | 1.28% | up 0.27 pts | ₹30.2 Cr | up ₹6.5 Cr | Added |
| Abbott Laboratories | 1.14% | down 0.06 pts | ₹26.9 Cr | down ₹1.1 Cr | Trimmed |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 0.88% | down 0.03 pts | ₹20.7 Cr | down ₹59 L | Trimmed |
| MedPlus Health Services Limited | 0.59% | up 0.02 pts | ₹14 Cr | up ₹66 L | Added |
| Pfizer Limited | 0.49% | up 0.03 pts | ₹11.7 Cr | up ₹89 L | Added |
| Jupiter Life Line Hospitals Limited | 0.48% | down 0.03 pts | ₹11.4 Cr | down ₹56 L | Trimmed |
What changed, Apr 2024 to May 2024
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Globus Medical Incup ₹37.8 Cr (+1.57% pts)
- Illumina Incup ₹24.6 Cr (+1.03% pts)
- Cipla Limitedup ₹20.9 Cr (+0.82% pts)
- Vijaya Diagnostic Centre Limitedup ₹11.6 Cr (+0.47% pts)
- Indoco Remedies Limitedup ₹7.5 Cr (+0.30% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Apr 2024, the weight rose most in Healthcare Equipment & Supplies (+1.8 pts) and Healthcare Services (+1.3 pts), and fell most in Pharmaceuticals & Biotechnology (−3.0 pts) and Insurance (−0.1 pts).
- Healthcare Equipment & Supplies6.5% → 8.3%+1.8 pts
- Healthcare Services14.0% → 15.3%+1.3 pts
- Pharmaceuticals5.5% → 5.6%+0.1 pts
- Pharmaceuticals & Biotechnology71.6% → 68.5%−3.0 pts
- Insurance1.8% → 1.7%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | May 2021 | May 2023 | Nov 2023 | Feb 2024 | Apr 2024 | May 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 63.3% | 71.2% | 73.5% | 70.8% | 71.6% | 68.5% |
| Healthcare Services | 21.1% | 13.3% | 12.0% | 14.0% | 14.0% | 15.3% |
| Healthcare Equipment & Supplies | 5.9% | 6.2% | 6.1% | 7.1% | 6.5% | 8.3% |
| Pharmaceuticals | 6.8% | 5.8% | 5.7% | 5.7% | 5.5% | 5.6% |
| Insurance | 2.8% | 2.3% | 1.9% | 1.8% | 1.8% | 1.7% |
| Retailing | — | 1.3% | 0.8% | 0.6% | 0.6% | 0.6% |
Allocation in May 2024change vs Apr 2024
- Pharmaceuticals & Biotechnology (13)68.5%▼ 3.0 pts
- Healthcare Services (6)15.3%▲ 1.3 pts
- Healthcare Equipment & Supplies (2)8.3%▲ 1.8 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, May 2024
1.3%
▲ 0.3 pts vs Apr 2024
- Cash alone
- 1.3%
- cash and net receivables
- A year earlier
- 0.4%
- May 2023 · now ▲ 0.9 pts
- Last 12 months
- 0.9% – 3.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.